Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions
Year: 2018
Type: editorial
Abstract: Lung cancer remains the leading cause of cancer-related death in the United States (1). Early stage (T1–T2N0) nonsmall cell lung carcinoma (NSCLC) accounts for 16% of new diagnoses, a proportion that is expected to rise with the implementation of low-dose CT screening programs (2).
Source: Journal of Thoracic Disease
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2791147472
